ImmunityBio, Inc.IBRX

時価総額

$22.8億

PER

	2015年 12月31日	2016年 12月31日	2017年 12月31日	2018年 12月31日	2019年 12月31日	2020年 12月31日	2021年 12月31日	2022年 12月31日
Cash and cash equivalents	176	8	24	17	16	11	181	105
Marketable securities	118	191	104	57	36	55	136	3
Due from related parties	-	1	0	0	-	-	1	2
Prepaid Expense and Other Assets, Current	-	5	4	14	4	9	16	32
Total current assets	-	205	132	89	56	75	334	141
Marketable securities, noncurrent	55	88	30	6	1	-	1	1
Property, plant and equipment, net	6	19	77	77	61	54	83	144
Intangible asset, net	-	5	3	1	-	-	1	20
Convertible note receivable	-	-	-	-	-	-	6	7
Operating Lease, Right-of-Use Asset	-	-	-	-	12	13	36	46
Other Assets, Noncurrent	1	1	0	2	4	1	7	5
Total assets	-	317	250	182	143	152	469	362
Accounts payable	2	4	6	3	2	4	11	21
Accrued expenses and other liabilities	-	-	-	-	-	-	51	42
Notes Payable, Related Parties, Current	-	-	-	-	-	-	-	432
Due to related parties	-	-	-	-	-	-	4	3
Operating Lease, Liability, Current	-	-	-	-	-	6	3	3
Total current liabilities	6	13	21	27	12	25	369	501
Notes Payable, Related Parties, Noncurrent	-	-	-	-	-	-	-	241
Operating Lease, Liability, Noncurrent	-	-	-	-	11	10	37	48
Warrant liability	-	-	-	-	-	-	-	22
Other liabilities	-	0	0	-	-	-	0	0
Total liabilities	-	24	32	36	22	34	713	812
Commitments and Contingencies	-	-	-	-	-	-	-	-
Common Stock, Value, Issued	0	0	0	0	0	0	0	0
Additional paid-in capital	607	681	718	741	783	872	1,720	1,931
Accumulated deficit	-	-387	-499	-595	-662	-755	-2,000	-2,400
Accumulated other comprehensive income	-0	-0	-0	-0	-0	-0	0	0
Total ImmunityBio stockholders’ deficit	356	293	219	146	121	117	-242	-447
Noncontrolling interests	-	-	-	-	-	-	-2	-2
Total stockholders’ deficit	-	-	-	-	-	-	-244	-450
Total liabilities and stockholders’ deficit	-	317	250	182	143	152	469	362